日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Beyond Recycling Antibodies: Crovalimab's Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment.

超越抗体回收利用:Crovalimab 的分子设计使其能够每四周进行一次皮下注射,用于治疗 PNH

Sampei Zenjiro, Haraya Kenta, Gan Siok Wan, Muraoka Masaru, Hayasaka Akira, Fukuzawa Taku, Shida-Kawazoe Meiri, Tsuboi Yoshinori, Gotoh Akihiko, Obara Naoshi, Ueda Yasutaka

Non-antigen-contacting region of an asymmetric bispecific antibody to factors IXa/X significantly affects factor VIII-mimetic activity

针对因子IXa/X的非对称双特异性抗体的非抗原接触区域显著影响因子VIII模拟活性。

Sampei, Zenjiro; Igawa, Tomoyuki; Soeda, Tetsuhiro; Funaki, Miho; Yoshihashi, Kazutaka; Kitazawa, Takehisa; Muto, Atsushi; Kojima, Tetsuo; Nakamura, Satoshi; Hattori, Kunihiro

Anti-factor IXa/X bispecific antibody ACE910 prevents joint bleeds in a long-term primate model of acquired hemophilia A

抗因子IXa/X双特异性抗体ACE910可预防获得性血友病A的长期灵长类动物模型中的关节出血。

Muto, Atsushi; Yoshihashi, Kazutaka; Takeda, Minako; Kitazawa, Takehisa; Soeda, Tetsuhiro; Igawa, Tomoyuki; Sampei, Zenjiro; Kuramochi, Taichi; Sakamoto, Akihisa; Haraya, Kenta; Adachi, Kenji; Kawabe, Yoshiki; Nogami, Keiji; Shima, Midori; Hattori, Kunihiro

Engineering the variable region of therapeutic IgG antibodies

对治疗性IgG抗体的可变区进行工程改造

Igawa, Tomoyuki; Tsunoda, Hiroyuki; Kuramochi, Taichi; Sampei, Zenjiro; Ishii, Shinya; Hattori, Kunihiro